Retraction Note: The hypoxia-inducible factor-1 regulates the microRNA185 expression through binding to hypoxia response elements sequence 2[Med Oncol, (2013), 30:756, DOI: 10.1007/s12032-013-0756-8];The hypoxia-inducible factor-1 regulates the microRNA185 expression through binding to hypoxia response elements sequence 2

Medical Oncology

Volumn 30, Issue 4, 2013, Pages

  Song, Zhenguo ^a   Ren, He ^a   Gao, Song ^a   Zhao, Tiansuo ^a   Wang, Xiuchao ^a   Zhang, Shengjie ^a   Zhao, Xiao ^a   Jia, Lingling ^a   Sun, Junwei ^a   Hao, Jihui ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

HIF 1; HRE2; MiR185; Pancreatic cancer

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; LUCIFERASE; MICRORNA; MICRORNA 185; UNCLASSIFIED DRUG; HIG1 PROTEIN, HUMAN; MIRN185 MICRORNA, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVE SITE; GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA RESPONSE ELEMENTS SEQUENCE 2; HYPOXIC CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; TUMOR VOLUME; WESTERN BLOTTING; CELL HYPOXIA; CHEMISTRY; DNA RESPONSIVE ELEMENT; ERRATUM; GENETICS; METABOLISM; PANCREAS TUMOR; RETRACTED ARTICLE; TUMOR CELL LINE;

CELL HYPOXIA; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS;

MLCS; MLOWN;

EID: 84886852683     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0436-3     Document Type: Erratum

References (21)

1. Knaup KX, Jozefowski K, Schmidt R, et al. Mutual regulation of hypoxia-inducible factor and mammalian target of rapamycin as a function of oxygen availability. Mol Cancer Res. 2009;7:88-98.
2. Maynard MA, Ohh M. The role of hypoxia-inducible factors in cancer. Cell Mol Life Sci. 2007;64:2170-80. (Pubitemid 350103108)
3. Ren H, Han ZB, Zhao H, et al. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor in response to hypoxia and epidermal growth factor. Carcinogenesis. 2008;29:1853-61.
4. Déry MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol. 2005;37:535-40. (Pubitemid 40022930)
5. Kizaka-Kondoh S, Tanaka S, Harada H, et al. The HIF-1-active microenvironment: an environmental target for cancer therapy. Adv Drug Deliv Rev. 2009;61(7-8):623-32.
6. Salceda S, Caro J. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem. 1997;272:22642-7. (Pubitemid 27386079)
7. Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol. 1992;12:5447-54.
8. Liu R, Chen X, Yiqi D, et al. Serum MicroRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem. 2012;3:610-8.
9. Sun HC, Qiu ZJ, Liu J, et al. Expression of hypoxia-inducible factor-1 alpha and associated proteins in pancreatic ductal adenocarcinoma and their impact on prognosis. Int J Oncol. 2007;30:1359-67.
10. -ΔΔCt method. Methods. 2001;25(4):402-8. (Pubitemid 34164012)
11. Zhao T, Gao S, Wang X, Liu J, Duan Y, et al. Hypoxia-inducible factor-1α regulates chemotactic migration of pancreatic ductal adenocarcinoma cells through directly transactivating the CX3CR1 gene. PLoS One. 2012;7(8):e43399. doi: 10.1371/journal.pone.0043399.
12. Sun W, Li J, Huang HD, Shyy JY, Chien S. microRNA: a master regulator of cellular processes for bioengineering systems. Annu Rev Biomed Eng. 2010;12:1-27.
13. Devlin C, Greco S, Martelli F, et al. miR-210: more than a silent player in hypoxia. IUBMB Life. 2011;63(2):94-100.
14. Berezikov E, Furyev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell. 2005;120(1):21-4. (Pubitemid 40094599)
15. Budhu A, Jia HL, Forgues M, et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology. 2008;47:897-907. (Pubitemid 351449681)
16. Gottardo F, Liu CG, Ferracin M, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007;25(5):387-92. (Pubitemid 47362758)
17. Yao Y, Suo AL, Li ZF, et al. MicroRNA profiling of human gastric cancer. Mol Med Report. 2009;2(6):963-70.
18. Takahashi Y, Forrest ARR, Maeno E, Hashimoto T, Daub CO, et al. MiR-107 and MiR-185 can induce cell cycle arrest in human non small cell lung cancer cell lines. PLoS ONE. 2009;4(8):e6677. doi: 10.1371/journal.pone.0006677.
19. Brown LM, Cowen RL, Debray C, et al. Reversing hypoxic cell chemoresistance in vitro using genetic and small molecule approaches targeting hypoxia inducible factor-1. Mol Pharmacol. 2006;69(2):411-8. (Pubitemid 43121938)
20. Kamura T, Sato S, Iwai K, et al. Activation of HIF1alpha ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex. Proc Natl Acad Sci USA. 2000;97(19):10430-5.
21. Grentzmann G, Ingram JA, Kelly PJ, et al. A dual-luciferase reporter system for studying recoding signals. RNA. 1998;4(4):479-86. (Pubitemid 28160788)